Clinical Trials Directory

Trials / Sponsors / Aligos Therapeutics

Aligos Therapeutics

Industry · 15 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
RecruitingSingle Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Pevifoscorvir Sodium (ALG-00018
Chronic Hepatitis B Infection
Phase 12026-02-20
RecruitingSingle-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Pevifoscorvir Sodium (ALG-0001
Chronic Hepaititis B Infections
Phase 12026-01-30
RecruitingA Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untrea
Chronic Hepatitis B Infection
Phase 22025-07-15
CompletedA Phase 1 Study in Healthy Volunteers to Evaluate the Relative Bioavailability of ALG-055009 Formulations
Healthy Volunteer Study
Phase 12025-03-25
CompletedA Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects With Renal Impairm
COVID 19
Phase 12025-02-01
CompletedA Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects With Hepatic Impai
COVID-19
Phase 12025-01-14
Active Not RecruitingA Multi-part Study of ALG-000184 to Evaluate Safety, Tolerability, Pharmacokinetics and Drug-drug Interaction
Healthy Volunteer
Phase 12025-01-09
CompletedALG-055009 in Non-cirrhotic Adults With MASH (HERALD)
NASH, MASH, Metabolic Dysfunction-Associated Steatohepatitis
Phase 22024-04-01
CompletedA Phase 1 Study to Evaluate the Drug-Drug Interaction Potential Between ALG-055009 and Statin Therapy(Ies)
Healthy Volunteers
Phase 12023-11-03
CompletedA First-in-Human Multi-Part Phase 1 Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmaco
COVID-19
Phase 12023-07-04
TerminatedA Study of ALG-125755 to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics After Single Do
Chronic Hepatitis B
Phase 12022-10-07
CompletedA Study of ALG-055009 in Healthy Volunteers and Subjects With Hyperlipidemia
NASH - Nonalcoholic Steatohepatitis
Phase 12021-12-01
TerminatedA Study of ALG-020572 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Singl
Chronic Hepatitis B
Phase 12021-09-25
CompletedA Study of ALG-000184 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Singl
Chronic Hepatitis B
Phase 12020-10-22
TerminatedA Study of ALG-010133 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Singl
Chronic Hepatitis B
Phase 12020-08-17